Research

Evaluation of Intra-articular Injuries as Predictors of Function and Arthritis

IRB Number: 23108
(trial not enrolling new patients)

Institutional Review Board, Hospital for Special Surgery

March 06, 2007

The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.

For further information, see Understanding Clinical Trials.

Principal Investigator

Robert G. Marx, MD

Co-Investigators

Sean Wilson

Summary

We will enroll patients of Dr. Robert Marx who undergo ACL reconstruction surgery.  Approximately 150 patients will be enrolled.  Patients receive follow up questionnaires at two, six and ten years after their surgery.

Inclusion/Exclusion Criteria

Inclusion criteria:
  • Patients undergoing unilateral ACL reconstruction
  • Age range: 10-85 years

Exclusion criteria:

  • Patients having had simultaneous bilateral ACL reconstruction
  • Age: <10 years, >85 years
     

Contact Information

Robert Marx MD
212.606.1645

Research Coordinator:
Sean Wilson
646. 797.8411
wilsonse@hss.edu



Request an Appointment